Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma

被引:130
作者
Breton, H
Cociglio, M
Bressolle, F
Peyriere, H
Blayac, JP
Hillaire-Buys, D [1 ]
机构
[1] Arnaud de Villeneuve Hosp, INSERM U454, Montpellier, France
[2] Lapeyronie Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France
[3] Lapeyronie Hosp, Therapeut Drug Monitoring Unit, Dept Med Pharmacol & Toxicol, F-34295 Montpellier, France
[4] Univ Montpellier 1, Fac Pharm, Clin Pharmacokinet Lab, Montpellier, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 828卷 / 1-2期
关键词
liquid chromatography-mass spectrometry; carbamazepine; oxcarbazepine; metabolites; validation;
D O I
10.1016/j.jchromb.2005.09.019
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Carbamazepine (CBZ) and oxcarbazepine (OXCBZ) are both antiepileptic drugs, which are prescribed as first-line drugs for the treatment of partial and generalized tonic-clonic epileptic seizures. In this paper, a specific and sensitive liquid chromatography-electrospray ionization mass spectrometry method was described for the simultaneous determination of carbamazepine (Cl3Z), oxcarbazepine (OXCBZ) and eight of their metabolites [CBZ-10,11-epoxide (CBZ-EP), 10,11-dihydro- 10,11-trans-dihydroxy-carbamazepine (DiOH-CBZ), 10-hydroxy-10,11-dihydroCBZ (10-OH-CBZ), 2-hydroxycarbamazepine (2-OH-CBZ), 3-hydroxycarbamazepine (3-OH-CBZ), iminostilbene (IM), acridone (AO) and acridine (AI)] in human plasma. The work-up procedure involved a simple precipitation with acetone. Separation of the analytes was achieved within 50 min using a Zorbax eclipse XD8 C8 analytical column. The mobile phase consisted of a mixture of acetonitrile-formate buffer (2 mM, pH 3). Detection was performed using a quadrupole mass spectrometer fitted with an electrospray ion source. Mass spectrometric data were acquired in single ion recording mode at m/z 237 for CBZ, m/z 180 for CBZ-EP and AI, m/z 236 for OXCBZ, m/z 237 for 10-OH-CBZ, m1z 253 for 2-OH-CBZ, 3-OH-CBZ and DiOH-CBZ, m/z 196 for AO and m1z 194 for IM. For all analytes, the drug/internal standard peak height ratios were linked via a quadratic relationship to plasma concentrations. The extraction recovery averaged 90% for CBZ, 80% for OXCBZ and was 80-105% for the metabolites. The lower limit of quantitation was 0.5 mg/l for CBZ, 0.4 mg/l for OXCBZ and ranged from 0.02 to 0.3 mg/l for the metabolites. Precision ranged from 2 to 13% and accuracy was between 86 and 112%. This method was found suitable for the analysis of plasma samples collected during therapeutic drug monitoring of patients treated with CBZ or OXCBZ. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 90
页数:11
相关论文
共 41 条
[1]  
ALBALLA S, 1987, J RHEUMATOL, V14, P559
[2]   Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human plasma by high-performance liquid chromatography with ultraviolet detection [J].
Bhatti, MM ;
Hanson, GD ;
Schultz, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 16 (07) :1233-1240
[3]   Validation of liquid chromatographic and gas chromatographic methods - Applications to pharmacokinetics [J].
Bressolle, F ;
BrometPetit, M ;
Audran, M .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 686 (01) :3-10
[4]   SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CARBAMAZEPINE AND ITS PRINCIPAL METABOLITES IN HUMAN-PLASMA AND URINE [J].
CHELBERG, RD ;
GUNAWAN, S ;
TREIMAN, DM .
THERAPEUTIC DRUG MONITORING, 1988, 10 (02) :188-193
[5]   IMINOSTILBENE - METABOLITE OF CARBAMAZEPINE ISOLATED FROM RAT URINE [J].
CSETENYI, J ;
BAKER, KM ;
FRIGERIO, A ;
MORSELLI, PL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) :340-341
[6]  
DUDCHE P, 1995, ANTIEPILEPTIC DRUGS, P555
[7]  
ETO S, 1995, BIOL PHARM BULL, V18, P926
[8]   FATAL APLASTIC-ANEMIA IN A PATIENT TREATED WITH CARBAMAZEPINE [J].
FRANCESCHI, M ;
CIBODDO, G ;
TRUCI, G ;
BORRI, A ;
CANAL, N .
EPILEPSIA, 1988, 29 (05) :582-583
[9]   THE EFFECT OF CARBAMAZEPINE AND ITS REACTIVE METABOLITE, 9-ACRIDINE CARBOXALDEHYDE, ON IMMUNE CELL-FUNCTION IN-VITRO [J].
FURST, SM ;
UETRECHT, JP .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (05) :445-452
[10]   CARBAMAZEPINE METABOLISM TO A REACTIVE INTERMEDIATE BY THE MYELOPEROXIDASE SYSTEM OF ACTIVATED NEUTROPHILS [J].
FURST, SM ;
UETRECHT, JP .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1267-1275